Friske Marion M, Spanagel Rainer
Institute of Psychopharmacology, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.
Alcohol Clin Exp Res (Hoboken). 2023 Apr;47(4):629-639. doi: 10.1111/acer.15041. Epub 2023 Feb 27.
During the COVID-19 pandemic, many potential risk groups have been identified, such as those with obesity, diabetes, preexisting organ injuries, and several other conditions. Smoking is the most reported substance use disorder linked to increased COVID-19 hospitalization rate and disease severity. In relation to smoking, we discuss the impairment of the innate and the adaptive immune systems as being among the main potential reasons for increased COVID-19 infection risk and severity. Chronic alcohol consumption and alcohol use disorder (AUD) also have a negative impact on the immune system, but when it comes to COVID-19 risk, they produce diverse outcomes. Some studies provide evidence that chronic alcohol consumption and AUD increase the risk of COVID-19 infection and severe disease progression, while others report reduced hospitalization and death rates. In this review, we summarize the current state of epidemiological and molecular data concerning alcohol consumption and AUD as risk factors for COVID-19 infection, hospitalization, and mortality.
在新冠疫情期间,已确定了许多潜在风险群体,如肥胖者、糖尿病患者、已有器官损伤者以及其他一些疾病患者。吸烟是报告最多的与新冠住院率和疾病严重程度增加相关的物质使用障碍。关于吸烟,我们讨论了先天免疫系统和适应性免疫系统的损害是新冠感染风险和严重程度增加的主要潜在原因之一。长期饮酒和酒精使用障碍(AUD)也会对免疫系统产生负面影响,但在新冠风险方面,它们会产生不同的结果。一些研究提供证据表明,长期饮酒和AUD会增加新冠感染风险和严重疾病进展,而其他研究则报告住院率和死亡率降低。在本综述中,我们总结了有关饮酒和AUD作为新冠感染、住院和死亡风险因素的流行病学和分子数据的现状。